De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade

Clinical trial NCT04675827 · TERMINATED

Trial details

NCT number: NCT04675827
Sponsor: Jules Bordet Institute
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

HER2-positive Breast Cancer ER-Negative Breast Cancer PR-Negative Breast Cancer Node-negative Breast Cancer

Start date: 2022-01-17
Primary completion: 2024-11-26
Enrollment: 139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.